Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Possibleidiot01on Jul 11, 2022 7:39am
165 Views
Post# 34814525

Premier Inc.

Premier Inc.You need to be happy about the 90% availabiity IMO.
Even if it's done at .a discount.

OpSens Inc. Logo (CNW Group/OpSens Inc.)

Louis Laflamme, President and CEO of OpSens, stated, "We are delighted to announce this agreement with one of the industry's largest group purchasing organizations. Collaborations like this one are an integral part of our strategy to expand the commercialization of the OptoWire in the U.S. and internationally, by increasing our cath lab access. Importantly, OpSens now has contracts in place covering over 90% of hospitals in the U.S. through group purchasing agreements."




<< Previous
Bullboard Posts
Next >>